-
OSMI-1 for Reproducible O-GlcNAc Assays
2026-09-15
A practical, scenario-based guide to using OSMI-1 (SKU B7923) in OGT inhibition, viability, and O-GlcNAcylation workflows. It explains dose interpretation, formulation, controls, safety limits, and vendor-selection criteria for more defensible cell-based results.
-
GVBE for Maternal Point Mutations in Pig Embryos
2026-09-15
The reference study introduces germinal vesicle oocyte base editing (GVBE), a strategy that edits maternal Dmd alleles during porcine oocyte maturation rather than after fertilization. Its embryo-level results show efficient formation of C>T-mutated alleles, while also revealing an important trade-off between editing and IVF blastocyst development.
-
Plant Nanovesicles Relieve Sertoli Cell Cycle Arrest
2026-09-14
This preprint identifies Cistanche deserticola-derived exosome-like nanovesicles (CDELNs) as a potential intervention for cyclophosphamide-induced testicular injury. Its central contribution is a mechanistic link between Sertoli-cell uptake mediated by heparan sulfate proteoglycans, delivery of miR159b-3p, suppression of P21, and restoration of CDK1-associated cell-cycle activity.
-
Cepharanthine for Reliable Apoptosis Assays
2026-09-14
This scenario-driven guide explains how Cepharanthine, SKU N2771, can support better-controlled viability, proliferation, and apoptosis workflows. It connects formulation, solvent control, organoid validation, mechanism-resolved readouts, and vendor-selection criteria to evidence from recent endometriosis models.
-
Cepharanthine Workflows for Apoptosis Research
2026-09-13
Build a translational Cepharanthine workflow that connects cell viability, patient-derived endometrial organoids, DNA-damage markers, and in vivo lesion analysis. This guide emphasizes model selection, formulation control, orthogonal apoptosis readouts, and practical troubleshooting rather than relying on a single endpoint.
-
SGC-CBP30 and the Hidden Logic of LUAD Super-Enhancers
2026-09-12
SGC-CBP30 offers a precise way to test whether CREBBP/EP300 bromodomain dependence helps sustain the LINC01977–TGF-β/SMAD3 program in lung adenocarcinoma. This thought-leadership analysis connects super-enhancer biology with experimental strategy while distinguishing established findings from translational hypotheses.
-
Koch-Like Validation of Xyleborus affinis Fungi
2026-09-12
A 2026 reference study combines improved mycangial isolation with host-colonisation assays to identify seven fungal associates of Xyleborus affinis, including four newly reported fungal partners. Its results show that ethanol-based recovery can underestimate fungal diversity and that detection is strengthened when fungal isolation is paired with functional colonisation evidence.
-
Cepharanthine Workflows for Endometriosis Research
2026-09-11
Build a translational Cepharanthine workflow that connects stromal-cell viability assays with patient-derived endometrial organoids and murine lesion models. Mechanism-resolved readouts for cell-cycle arrest, DNA damage, and apoptosis help distinguish disease-relevant activity from nonspecific solvent or culture effects.
-
SCH772984: Rethinking ERK1/2 Inhibition in Translation
2026-09-11
A translational framework for using SCH772984 to interrogate ERK signaling, mutant-driven tumor biology, and radioresistance while connecting MAPK output to the Ang II–HIF-1α–HILPDA axis in nasopharyngeal carcinoma.
-
AT13387: Hsp90 Inhibition Beyond Viability
2026-09-10
Explore how AT13387, a high-affinity Hsp90 inhibitor, can support mechanistic cancer biology research beyond simple viability assays. This article connects proteostasis disruption, apoptosis induction, and the NINJ1-dependent secretion findings reported in norovirus research while defining practical assay boundaries.
-
Ibotenic Acid for Circuit and Disease Models
2026-09-10
Ibotenic acid is a dual glutamate-receptor agonist for controlled excitotoxic perturbation, lesion-based circuit mapping, and neurodegenerative disease modeling. This guide connects product handling with the brain-to-spinal pain-circuit findings of Huo et al., while separating validated evidence from practical assay recommendations.
-
NSP2–MYB40 Control of Flavonoids and Symbiosis
2026-09-09
Gao and colleagues identify an NSP2–MYB40 regulatory module that connects nutrient-responsive flavonoid biosynthesis with rhizobial nodulation and arbuscular mycorrhizal colonization. The study combines genetic, transcriptional, promoter-binding, and protein-interaction evidence to explain how legumes tune symbiotic nutrient acquisition under changing conditions.
-
PDGF-BB, murine recombinant protein in Cell Assays
2026-09-09
This scenario-based guide explains how PDGF-BB, murine recombinant protein supports controlled proliferation, viability, and cytotoxicity workflows. It covers receptor biology, assay design, reconstitution, interpretation, and vendor-selection criteria using SKU P1048 as a practical reference.
-
From α2-AR Signaling to Osteosarcoma Recurrence
2026-09-08
A translational framework for using 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine to investigate α2-adrenergic receptor signaling, immune rejection modulation, and local strategies for post-surgery osteosarcoma recurrence treatment research.
-
AZ505: Translating SMYD2 Inhibition Beyond Cancer
2026-09-08
AZ505 offers a mechanistically defined route to interrogate SMYD2-dependent methylation in cancer biology research, epigenetic regulation research, and fibrosis models. This article connects its substrate-competitive design with peer-reviewed evidence from cisplatin-induced renal fibrosis while outlining practical, translationally relevant study strategies.